Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia

Immunology and Cell Biology

Volumn 84, Issue 2, 2006, Pages 115-124

  Mitra, Amit K ^a   Gangahar, Deepak M ^b   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Nebraska Heart Hospital   (United States)

Author keywords

Atherosclerosis; Cell proliferation; Coronary artery bypass graft (CABG); Immune mechanism; Intimal hyperplasia

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; CYTOSTATIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; HEPARIN; OLIGODEOXYNUCLEOTIDE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B BETA; RAPAMYCIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR E2F; TRANSFORMING GROWTH FACTOR BETA;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL WALL; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; GENE TARGETING; HUMAN; IN-STENT RESTENOSIS; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; VEIN GRAFT; VEIN GRAFT DISEASE; VEIN GRAFT INTIMAL HYPERPLASIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ARTERIAL OCCLUSIVE DISEASES; CORONARY ARTERY BYPASS; GRAFT OCCLUSION, VASCULAR; GRAFT SURVIVAL; GROWTH SUBSTANCES; HUMANS; HYPERPLASIA; IMMUNITY, CELLULAR; LEUKOCYTES; MYOCARDIAL INFARCTION; ONCOGENE PROTEIN V-AKT; SIGNAL TRANSDUCTION; TUNICA INTIMA;

THROMBUS;

EID: 33644745116     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01407.x     Document Type: Review

References (145)

1. Fitzgibbon GM Kafka HP Leach AJ Keon WJ Hooper GD Burton JR Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J. Am. Coll. Cardiol 1996 28 616 26
2. Veith FJ Gupta SK Ascer E et al Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions J. Vasc. Surg 1986 3 104 14
3. Stary HC The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life Eur. Heart J 1990 11 Suppl. E 3 19
4. Timpl R Macromolecular organization of basement membranes Curr. Opin. Cell Biol 1996 8 618 24
5. Davies MG Hagen PO Pathophysiology of vein graft failure: a review Eur. J. Vasc. Endovasc. Surg 1995 9 7 18
6. Clowes AW Karnowsky MJ Suppression by heparin of smooth muscle cell proliferation in injured arteries Nature 1977 265 625 6
7. Snow AD Bolender RP Wight TN Clowes AW Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells Am. J. Pathol 1990 137 313 30
8. Lindner V Olson NE Clowes AW Reidy MA Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor J. Clin. Invest 1992 90 2044 9
9. Reilly CF McFall RC Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells J. Biol. Chem 1991 266 9419 27
10. Griffith TM Studies of endothelium-derived relaxant factor (EDRF), its nature and mode of action Eur. Heart J 1985 6 37 49
11. Furchgott RF Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide Biosci. Rep 1999 19 235 51
12. Palmer RM Ferrige AG Moncada S Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 1987 327 524 6
13. Preli RB Klein KP Herrington DM Vascular effects of dietary L -arginine supplementation Atherosclerosis 2002 162 1 15
14. Radomski MW Palmer RM Moncada S The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide Br. J. Pharmacol 1987 92 639 46
15. Bath PM Hassall DG Gladwin AM Palmer RM Martin JF Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro Arterioscler. Thromb 1991 11 254 60
16. Joannides R Haefeli WE Linder L et al Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo Circulation 1995 91 1314 19
17. Yang ZH von Segesser L Bauer E Stulz P Turina M Luscher TF Different activation of the endothelial L -arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein Circ. Res 1991 68 52 60
18. Werner GS Wiegand V Kreuzer H Effect of acetylcholine on arterial and venous grafts and coronary arteries in patients with coronary artery disease Eur. Heart J 1990 11 127 37
19. Clozel M Fischli W Human cultured endothelial cells do secrete endothelin-1 J. Cardiovasc. Pharmacol 1989 13 Suppl 5 S229 31
20. Yanagisawa M Kurihara H Kimura S et al A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 1988 332 411 15
21. Miller VM Komori K Burnett JC Jr. Vanhoutte PM Differential sensitivity to endothelin in canine arteries and veins Am. J. Physiol 1989 257 H1127 31
22. Luscher TF Diederich D Siebenmann R et al Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts N. Engl. J. Med 1988 319 462 7
23. Mann JM McIntosh CL Roberts WC Spasm of saphenous veins used as conduits for aortocoronary bypass grafting Am. J. Cardiol 1987 59 1000 1002
24. Victor MF Kimbiris D Iskandrian AS et al Spasm of a saphenous vein bypass graft. A possible mechanism for occlusion of the venous graft Chest 1981 80 413 15
25. Corson JD Leather RP Balko A Naraynsingh V Karmody AM Shah DM Relationship between vasa vasorum and blood flow to vein bypass endothelial morphology Arch. Surg 1985 120 386 8
26. Spray TL Roberts WC Changes in saphenous veins used as aortocoronary bypass grafts Am. Heart J 1977 94 500 16
27. McGeachie JK Meagher S Prendergast FJ Vein-to-artery grafts: the long-term development of neo-intimal hyperplasia and its relationship to vasa vasorum and sympathetic innervation Aust. NZJ. Surg 1989 59 59 65
28. Kennedy JH Lever MJ Addis BJ Paneth M Changes in vein interstitium following distension for aortocoronary bypass J. Cardiovasc. Surg. (Torino) 1989 30 992 5
29. Zwolak RM Adams MC Clowes AW Kinetics of vein graft hyperplasia: association with tangential stress J. Vasc. Surg 1987 5 126 36
30. Langille BL O'Donnell F Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent Science 1986 231 405 407
31. Barboriak JJ Pintar K Korns ME Atherosclerosis in aortocoronary vein grafts Lancet 1974 2 621 4
32. Grondin CM Graft disease in patients with coronary bypass grafting. Why does it start? Where do we stop? J. Thorac. Cardiovasc. Surg 1986 92 323 9
33. Kalan JM Roberts WC Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins Am. Heart J 1990 119 1164 84
34. Fuchs JC Mitchener JS III. Hagen PO Postoperative changes in autologous vein grafts Ann. Surg 1978 188 1 15
35. Ratliff NB Myles JL Rapidly progressive atherosclerosis in aortocoronary saphenous vein grafts. Possible immune-mediated disease Arch. Pathol. Lab. Med 1989 113 772 6
36. Wilentz JR Sanborn TA Haudenschild CC Valeri CR Ryan TJ Faxon DP Platelet accumulation in experimental angioplasty: time course and relation to vascular injury Circulation 1987 75 636 42
37. Davies MG Hagen PO Pathobiology of intimal hyperplasia Br. J. Surg 1994 81 1254 69
38. Lee MS David EM Makkar RR Wilentz JR Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leucocytes, and the coagulation-fibrinolysis system J. Pathol 2004 203 861 70
39. Ishiwata S Tukada T Nakanishi S Nishiyama S Seki A Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis Am. Heart J 1997 133 387 92
40. Henn V Slupsky JR Grafe M et al CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Nature 1998 391 591 4
41. Aukrust P Muller F Ueland T et al Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes Circulation 1999 100 614 20
42. Handa K Nudelman ED Stroud MR Shiozawa T Hakomori S Selectin GMP-140 (CD62; PADGEM) binds to sialosyl-Le(a) and sialosyl-Le(x), and sulfated glycans modulate this binding Biochem. Biophys. Res. Commun 1991 181 1223 30
43. Piek JJ van der Wal AC Meuwissen M et al Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina J. Am. Coll. Cardiol 2000 35 963 7
44. Diacovo TG Roth SJ Buccola JM Bainton DF Springer TA Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18 Blood 1996 88 146 57
45. McEver RP Cummings RD Role of PSGL-1 binding to selectins in leucocyte recruitment J. Clin. Invest 1997 100 S97 103
46. Simon DI Chen Z Xu H et al Platelet glycoprotein ibalpha is a counterreceptor for the leucocyte integrin Mac-1 (CD11b/CD18) J. Exp. Med 2000 192 193 204
47. Diacovo TG deFougerolles AR Bainton DF Springer TA A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2 J. Clin. Invest 1994 94 1243 51
48. Wainwright CL Miller AM Wadsworth RM Inflammation as a key event in the development of neointima following vascular balloon injury Clin. Exp. Pharmacol. Physiol 2001 28 891 5
49. Inoue T Sohma R Miyazaki T Iwasaki Y Yaguchi I Morooka S Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris Am. J. Cardiol 2000 86 1057 62
50. Horvath C Welt FG Nedelman M Rao P Rogers C Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leucocytes targeted Circ. Res 2002 90 488 94
51. Gotoh R Suzuki J Kosuge H et al E-selectin blockade decreases adventitial inflammation and attenuates intimal hyperplasia in rat carotid arteries after balloon injury Arterioscler. Thromb. Vasc. Biol 2004 24 2063 8
52. Edgington TS Mackman N Brand K Ruf W The structural biology of expression and function of tissue factor Thromb. Haemost 1991 66 67 79
53. Hasenstab D Lea H Hart CE Lok S Clowes AW Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis Circulation 2000 101 2651 7
54. Huynh TT Davies MG Thompson MA Ezekowitz MD Hagen P Annex BH Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts J. Vasc. Surg 2001 33 400 407
55. Giesen PL Rauch U Bohrmann B et al Blood-borne tissue factor: another view of thrombosis Proc. Natl Acad. Sci. USA 1999 96 2311 15
56. Mackman N Role of tissue factor in hemostasis, thrombosis, and vascular development Arterioscler. Thromb. Vasc. Biol 2004 24 1015 22
57. McNamara CA Sarembock IJ Bachhuber BG et al Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis Semin. Thromb. Hemost 1996 22 139 44
58. Libby P Sukhova G Lee RT Liao JK Molecular biology of atherosclerosis Int. J. Cardiol 1997 62 Suppl 2 S23 9
59. Schwartz SM Smooth muscle migration in atherosclerosis and restenosis J. Clin. Invest 1997 100 S87 9
60. Schwartz SM Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis J. Clin. Invest 1997 99 2814 16
61. Kaneider NC Reinisch CM Dunzendorfer S Meierhofer C Djanani A Wiedermann CJ Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin Atherosclerosis 2001 158 23 33
62. Schachter M Vascular smooth muscle cell migration, atherosclerosis, and calcium channel blockers Int. J. Cardiol 1997 62 Suppl 2 S85 90
63. Allaire E Clowes AW Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response Ann. Thorac. Surg 1997 63 582 91
64. Davis C Fischer J Ley K Sarembock IJ The role of inflammation in vascular injury and repair J. Thromb. Haemost 2003 1 1699 709
65. Newby AC Zaltsman AB Molecular mechanisms in intimal hyperplasia J. Pathol 2000 190 300 309
66. Berk BC Vascular smooth muscle growth: autocrine growth mechanisms Physiol. Rev 2001 81 999 1030
67. Clowes AW Reidy MA Clowes MM Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium Lab. Invest 1983 49 327 33
68. Madri JA Bell L Marx M Merwin JR Basson C Prinz C Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: models of de-endothelialization and repair J. Cell. Biochem 1991 45 123 30
69. Merwin JR Newman W Beall LD Tucker A Madri J Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro Am. J. Pathol 1991 138 37 51
70. Shi Y Niculescu R Wang D Patel S Davenpeck KL Zalewski A Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury Arterioscler. Thromb. Vasc. Biol 2001 21 739 45
71. Rey FE Pagano PJ The reactive adventitia: fibroblast oxidase in vascular function Arterioscler. Thromb. Vasc. Biol 2002 22 1962 71
72. Uchida K Sasahara M Morigami N Hazama F Kinoshita M Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries Atherosclerosis 1996 124 9 23
73. Bornfeldt KE Raines EW Nakano T Graves LM Krebs EG Ross R Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation J. Clin. Invest 1994 93 1266 74
74. Tanizawa S Ueda M van der Loos CM van der Wal AC Becker AE Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study Heart 1996 75 549 56
75. Rakesh K Agrawal DK Cytokines and growth factors involved in control and proliferation of apoptotic smooth muscle cells Int. Immunopharmacol 2005 5 1487 506
76. Saltiel AR Kahn CR Insulin signalling and the regulation of glucose and lipid metabolism Nature 2001 414 799 806
77. Stewart CE Rotwein P Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors Physiol. Rev 1996 76 1005 26
78. Wymann MP Pirola L Structure and function of phosphoinositide 3-kinases Biochim. Biophys. Acta 1998 1436 127 50
79. Lymn JS Rao SJ Clunn GF et al Phosphatidylinositol 3-kinase and focal adhesion kinase are early signals in the growth factor-like responses to thrombospondin-1 seen in human vascular smooth muscle Arterioscler. Thromb. Vasc. Biol 1999 19 2133 40
80. Reiske HR Kao SC Cary LA Guan JL Lai JF Chen HC Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration J. Biol. Chem 1999 274 12 361 6
81. Cobb MH MAP kinase pathways Prog. Biophys. Mol. Biol 1999 71 479 500
82. Garrington TP Johnson GL Organization and regulation of mitogen-activated protein kinase signaling pathways Curr. Opin. Cell Biol 1999 11 211 18
83. Lewis TS Shapiro PS Ahn NG Signal transduction through MAP kinase cascades Adv. Cancer Res 1998 74 49 139
84. Franke TF Kaplan DR Cantley LC PI3K: downstream AKTion blocks apoptosis Cell 1997 88 435 7
85. Burgering BM Coffer PJ Protein kinase B (c-Akt) in phosphatidylinositol- 3-OH kinase signal transduction Nature 1995 376 599 602
86. Franke TF Yang SI Chan TO et al The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase Cell 1995 81 727 36
87. Brunet A Bonni A Zigmond MJ et al Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 1999 96 857 68
88. Cantley LC Neel BG New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway Proc. Natl Acad. Sci. USA 1999 96 4240 45
89. Bennett MR Evan GI Schwartz SM Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques J. Clin. Invest 1995 95 2266 74
90. LaBelle EF Tulenko TN LDL, IGF-1, and VSMC apoptosis: linking atherogenesis to plaque rupture in vulnerable lesions Cardiovasc. Res 2004 61 204 5
91. Rakesh K Agrawal DK Controlling cytokine signaling by constitutive inhibitors Biochem. Pharmacol 2005 70 649 57
92. Dey BR Spence SL Nissley P Furlanetto RW Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor J. Biol. Chem 1998 273 24 095 101
93. Starr R Willson TA Viney EM et al A family of cytokine-inducible inhibitors of signalling Nature 1997 387 917 21
94. Li JM Brooks G Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy? Eur. Heart J 1999 20 406 20
95. Cadena DL Gill GN Receptor tyrosine kinases FASEB J 1992 6 2332 7
96. Berra E Diaz-Meco MT Dominguez I et al Protein kinase C zeta isoform is critical for mitogenic signal transduction Cell 1993 74 555 63
97. Datta SR Brunet A Greenberg ME Cellular survival: a play in three Akts Genes Dev 1999 13 2905 27
98. Scheid MP Woodgett JR PKB/AKT: functional insights from genetic models Nat. Rev. Mol. Cell Biol 2001 2 760 8
99. Brazil DP Hemmings BA Ten years of protein kinase B signalling: a hard Akt to follow Trends Biochem. Sci 2001 26 657 64
100. Toker A Newton AC Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site J. Biol. Chem 2000 275 8271 4
101. Millward TA Zolnierowicz S Hemmings BA Regulation of protein kinase cascades by protein phosphatase 2A Trends Biochem. Sci 1999 24 186 91
102. Cohen P Frame S The renaissance of GSK3 Nat. Rev. Mol. Cell Biol 2001 2 769 76
103. Scott PH Brunn GJ Kohn AD Roth RA Lawrence JC Jr. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway Proc. Natl. Acad. Sci. USA 1998 95 7772 7
104. Johnson DG Walker CL Cyclins and cell cycle checkpoints Annu. Rev. Pharmacol. Toxicol 1999 39 295 312
105. Sherr CJ Roberts JM CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev 1999 13 1501 12
106. Sherr CJ Cancer cell cycles Science 1996 274 1672 7
107. Dzau VJ Braun-Dullaeus RC Sedding DG Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies Nat. Med 2002 8 1249 56
108. Grise MA Massullo V Jani S et al Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial Circulation 2002 105 2737 40
109. Teirstein P Beta-radiation to reduce restenosis. Too little, too soon? Circulation 1997 95 1095 7
110. Teirstein PS Massullo V Jani S et al Catheter-based radiotherapy to inhibit restenosis after coronary stenting N. Engl. J. Med 1997 336 1697 703
111. Morice MC Serruys PW Sousa JE et al A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N. Engl. J. Med 2002 346 1773 80
112. Mangi AA Dzau VJ Gene therapy for human bypass grafts Ann. Med 2001 33 153 5
113. McEver RP Selectins Curr. Opin. Immunol 1994 6 75 84
114. Dong ZM Chapman SM Brown AA Frenette PS Hynes RO Wagner DD The combined role of P- and E-selectins in atherosclerosis J. Clin. Invest 1998 102 145 52
115. Dong ZM Brown AA Wagner DD Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice Circulation 2000 101 2290 5
116. Shih PT Brennan ML Vora DK et al Blocking very late antigen-4 integrin decreases leucocyte entry and fatty streak formation in mice fed an atherogenic diet Circ. Res 1999 84 345 51
117. Collins RG Velji R Guevara NV Hicks MJ Chan L Beaudet AL P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice J. Exp. Med 2000 191 189 94
118. Gerrity RG The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions Am. J. Pathol 1981 103 181 90
119. Napoli C D'Armiento FP Mancini FP et al Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions J. Clin. Invest 1997 100 2680 90
120. Smith JD Trogan E Ginsberg M Grigaux C Tian J Miyata M Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E Proc. Natl Acad. Sci. USA 1995 92 8264 8
121. Goldstein JL Ho YK Basu SK Brown MS Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition Proc. Natl Acad. Sci. USA 1979 76 333 7
122. Steinbrecher UP Witztum JL Parthasarathy S Steinberg D Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism Arteriosclerosis 1987 7 135 43
123. Akira S Takeda K Kaisho T Toll-like receptors: critical proteins linking innate and acquired immunity Nat. Immunol 2001 2 675 80
124. Kodama T Reddy P Kishimoto C Krieger M Purification and characterization of a bovine acetyl low density lipoprotein receptor Proc. Natl Acad. Sci. USA 1988 85 9238 42
125. Steinbrecher UP Receptors for oxidized low density lipoprotein Biochim. Biophys. Acta 1999 1436 279 98
126. Abraham R Choudhury A Basu SK Bal V Rath S Disruption of T cell tolerance by directing a self antigen to macrophage-specific scavenger receptors J. Immunol 1997 158 4029 35
127. Nicoletti A Caligiuri G Tornberg I Kodama T Stemme S Hansson GK The macrophage scavenger receptor type A directs modified proteins to antigen presentation Eur. J. Immunol 1999 29 512 21
128. Febbraio M Podrez EA Smith JD et al Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice J. Clin. Invest 2000 105 1049 56
129. Shimaoka T Kume N Minami M et al Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages J. Biol. Chem 2000 275 40 663 6
130. Unanue ER Antigen-presenting function of the macrophage Annu. Rev. Immunol 1984 2 395 428
131. Stemme S Holm J Hansson GK T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1 Arterioscler. Thromb 1992 12 206 11
132. Swain SL Bradley LM Helper T cell memory: more questions than answers Semin. Immunol 1992 4 59 68
133. Sprent J Surh CD Generation and maintenance of memory T cells Curr. Opin. Immunol 2001 13 248 54
134. Lanzavecchia A Sallusto F Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells Science 2000 290 92 7
135. Mosmann TR Sad S The expanding universe of T-cell subsets: Th1, Th2 and more Immunol. Today 1996 17 138 46
136. Hansson GK Jonasson L Holm J Clowes MM Clowes AW Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro Circ. Res 1988 63 712 19
137. Jonasson L Holm J Skalli O Gabbiani G Hansson GK Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis J. Clin. Invest 1985 76 125 31
138. Mach F Schonbeck U Sukhova GK et al Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis Proc. Natl Acad. Sci. USA 1997 94 1931 6
139. Gupta S Pablo AM Jiang X Wang N Tall AR Schindler C IFN-gamma potentiates atherosclerosis in ApoE knock-out mice J. Clin. Invest 1997 99 2752 61
140. Frostegard J Ulfgren AK Nyberg P et al Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines Atherosclerosis 1999 145 33 43
141. Sohma Y Sasano H Shiga R et al Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits Proc. Natl Acad. Sci. USA 1995 92 4937 41
142. Salonen JT Yla-Herttuala S Yamamoto R et al Autoantibody against oxidised LDL and progression of carotid atherosclerosis Lancet 1992 339 883 7
143. Heyman B Regulation of antibody responses via antibodies, complement, and Fc receptors Annu. Rev. Immunol 2000 18 709 37
144. Nemazee D Receptor selection in B and T lymphocytes Annu. Rev. Immunol 2000 18 19 51
145. Baumgarth N A two-phase model of B-cell activation Immunol. Rev 2000 176 171 80